| |
| |
|
| Insider
Information: |
Rouan Sarah Kathryn |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
18,242 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,652 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,242 |
|
|
| Total
Value |
$2,652 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Navidea Biopharmaceuticals |
NAVB |
Director |
2021-06-30 |
18,242 |
2019-01-02 |
0 |
Premium* |
|
|
Viking Therapeutics, Inc. |
VKTX |
Director |
2024-02-08 |
0 |
2024-01-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VKTX |
Viking Therapeutics, Inc. |
Director |
– • – |
2024-02-08 |
4 |
AS |
$28.05 |
$701,250 |
D/D |
(25,000) |
0 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
Director |
– • – |
2024-02-08 |
4 |
OE |
$8.32 |
$208,000 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Director |
– • – |
2024-01-19 |
4 |
AS |
$23.05 |
$691,500 |
D/D |
(30,000) |
0 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
Director |
– • – |
2024-01-19 |
4 |
OE |
$8.32 |
$249,600 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,892 |
18,242 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2021-01-13 |
4 |
A |
$0.00 |
$3 |
D/D |
2,500 |
13,350 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2020-02-06 |
4 |
A |
$0.00 |
$3 |
D/D |
2,500 |
10,850 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2019-05-17 |
4 |
B |
$1.46 |
$4,904 |
D/D |
3,350 |
8,350 |
2.31 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2019-02-07 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
100,000 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2019-01-02 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
50,000 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
